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PExercise Hypertension
Exaggerated Blood Pressure
Response to Exercise Is Associated With
Augmented Rise of Angiotensin II During Exercise
Chi Young Shim, MD, Jong-Won Ha, MD, PHD, Sungha Park, MD, PHD, Eui-Young Choi, MD,
Donghoon Choi, MD, PHD, Se-Joong Rim, MD, PHD, Namsik Chung, MD, PHD
Seoul, South Korea
Objectives The aim of this study was to investigate the association between an exaggerated blood pressure (BP) response
to exercise and augmented angiotensin (Ang) II rise during exercise.
Background Although a central pressor effect of Ang II has been implicated in the pathogenesis of hypertension, the relation-
ship between Ang II and exaggerated BP response to exercise is unclear.
Methods Thirty-six subjects with an exaggerated BP response to exercise (18 men, age 50  16 years, Group II) were
compared with 36 age- and gender-matched control subjects (18 men, age 50  16 years, Group I) with normal
BP reactivity. The subjects who had resting BP 140/90 mm Hg or were treated with any antihypertensive
drugs were excluded. The blood was sampled at rest and immediately after peak exercise for measurement of
renin, Ang II, aldosterone, and catecholamine.
Results At rest, there were no significant differences in BP, renin, aldosterone, and catecholamine levels between the 2
groups. The renin, aldosterone, and catecholamine were increased during exercise, but there were no significant
differences between the groups. However, log Ang II at rest (0.78  0.32 vs. 0.98  0.38, p  0.004) and peak
exercise (0.84  0.35 vs. 1.17  0.51, p  0.001) and the magnitude of the increment of log Ang II with exer-
cise (0.06  0.12 vs. 0.19  0.20, p  0.003) were significantly higher in the exaggerated BP response group.
Conclusions An exaggerated BP response to exercise was associated with augmented rise of Ang II during exercise. (J Am
Coll Cardiol 2008;52:287–92) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.03.052r
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2n exaggerated blood pressure (BP) response to exercise is
ssociated with a 2 to 3 times greater risk of future
evelopment of hypertension (1–3) and a greater prevalence
f left ventricular (LV) hypertrophy (4,5) in otherwise
ormotensive participants. The association between an ab-
ormal rise in systolic BP during exercise and cardiovascular
orbidity has been suggested, but its mechanism has not
een clearly elucidated. It has been suggested that BP and
eart rate increments during exercise are related to stimu-
ation of the sympathetic nervous system and the renin-
ngiotensin-aldosterone system during exercise (6 – 8).
owever, neurohormonal differences have not been studied
ully between subjects who have an exaggerated BP response
o exercise and who have normal BP reactivity. In the
resent study, we hypothesized that an exaggerated BP
rom the Cardiology Division, Yonsei Cardiovascular Center, Yonsei University
ollege of Medicine, Seoul, South Korea. This work was supported by the Korea
cience and Engineering Foundation (KOSEF) grant funded by the Korean govern-
ent (M10642120001-06N4212-00110).n
Manuscript received January 11, 2008; revised manuscript received March 10,
008, accepted March 10, 2008.esponse to exercise is associated with augmented angioten-
in (Ang) II rise during exercise. To prove our hypothesis,
e investigated neurohormonal changes such as renin, Ang
I, aldosterone, and catecholamine at rest and immediately
fter peak exercise in subjects with an exaggerated BP
esponse to exercise and compared them with neurohor-
onal changes in control subjects who have normal BP
eactivity.
ethods
tudy subjects. The study subjects consisted of patients
ho were referred for exercise Doppler echocardiography
or the evaluation of coronary artery disease or exercise-
nduced diastolic dysfunction as the cause of exertional
yspnea during the period between October 2005 and May
006. At the initial enrollment, patients underwent a
omplete physical examination, a baseline electrocardio-
ram, and laboratory assessment. Inclusion criteria included
esting BP140/90 mm Hg, LV ejection fraction55% by
-dimensional echocardiography, no valvular heart disease,
o significant systemic disease, and no evidence of renal
t
e
4
m
r
b
i
e
p
1
s
w
e
m
c
a
G
e
s
t
E
r
b
M
n
o
m
t
w
S
c
i
w
d
f
l
[
e
w
e
t
a
o
m
i
N
c
s
s
i
r
(
w
t
i
t
P
p

(
r
m
T
(
9
A
i
o
3
a
A
S
a
r
g
v
I
n
T
t
t
e
w
I
R
B
s
s
d
t
T
d
s
t
288 Shim et al. JACC Vol. 52, No. 4, 2008
Angiotensin II and Exercise BP July 22, 2008:287–92insufficiency (serum creatinine
1.5 mg/ml). The subjects who
were treated with any antihyper-
tensive drugs or vasodilators were
also excluded. Among the 286
subjects who received the exer-
cise stress echocardiography, 131
subjects (61 men, mean age 48
16 years) satisfied the entry cri-
teria completely. Each subject
provided informed, written con-
sent to the protocol that had
been approved by our institu-
ional review board. The mean change in systolic BP with
xercise echocardiography was 55  21 mm Hg in men and
6  25 mm Hg in women. Among the 131 subjects, 26
en and 23 women met the definition of an exaggerated BP
esponse to exercise defined as difference of peak and
aseline systolic BP 60 mm Hg in men and 50 mm Hg
n women during exercise echocardiography. After the
xercise test, 3 subjects (2 men, 1 woman) who showed
ositive exercise echocardiogram for inducible ischemia and
0 subjects (6 men, 4 women) with insufficient blood
amples either at rest or immediately after peak exercise
ere additionally excluded. Finally, 36 subjects with an
xaggerated BP response to exercise (Group II, 18 men,
ean age 50  16 years) and 36 age- and gender-matched
ontrol subjects with normal BP reactivity (Group I) were
nalyzed. Among the 72 subjects analyzed, 16 subjects (9 in
roup I, 7 in Group II) were previously diagnosed with
ssential hypertension. However, the resting BP of all
ubjects was140/90 mm Hg without any antihypertensive
reatments.
xercise protocol. The exercise test with simultaneous
espiratory gas analysis was performed using a variable load
icycle ergometer (Medical Positioning Inc., Kansas City,
issouri) at a supine position. Echocardiographic exami-
ation was performed simultaneously as described previ-
usly (9). Briefly, after obtaining the rest of the images, a
ultistage supine bicycle exercise test was performed. From
he resting images, standard 2-dimensional measurements
ere performed as a recommendation of the American
ociety of Echocardiography (10). Stroke volume (SV) was
alculated by multiplying LV outflow tract area by the time
ntegral of the outflow tract velocity measured by pulsed
ave Doppler. Left ventricular outflow tract area was
etermined as (D/2)2, where D is its diameter measured
rom a zoomed systolic freeze frame in the parasternal
ong-axis view. End-systolic pressure was approximated by
(2  systolic BP  diastolic BP)/3]. The effective arterial
lastance was the ratio of end systolic pressure to SV (11).
The subjects pedaled at a constant speed beginning at a
orkload of 25 W, with an incremental workload of 25 W
very 3 min until limited by their symptoms. Peak exercise
ime was recorded in seconds. Peak workload was estimated
Abbreviations
and Acronyms
Ang  angiotensin
BP  blood pressure
Epi  epinephrine
LV  left
ventricle/ventricular
NE  norepinephrine
PRA  plasma renin
activity
SV  stroke volumes metabolic equivalents. The BP was measured at the end df each stage of exercise on the left arm using an oscillo-
etric BP monitoring device (Solar 8000M patient monitor-
ng device, GE Medical Systems, Milwaukee, Wisconsin).
eurohormonal assessment. A small flexible intravenous
annular was inserted into the forearm vein for blood
ampling. The blood samples were obtained with the
ubjects at rest (after 5 min of rest in supine position) and
mmediately after peak exercise for measurements of plasma
enin, Ang II, serum aldosterone, and plasma catecholamine
epinephrine [Epi] and norepinephrine [NE]). Samples
ere drawn into ethylenediaminetetraacetic acid–treated
ubes and plain tubes. The tubes were immediately placed in
ce and immediately centrifuged. The plasma and serum
hen were separated and stored at 70°C until analysis.
lasma Epi and NE levels were measured by high-
erformance liquid chromatography (normal range of Epi:
300 pg/ml, NE: 800 pg/ml) (12). Plasma renin activity
PRA), plasma Ang II concentration, and serum aldoste-
one were measured using commercially available radioim-
unoassay kits, level of PRA (Renin RIA beads, SRL Inc.,
okyo, Japan, normal range 0.68 to 1.36 ng/ml/h), Ang II
Angiotensin II kits, SRL Inc., Tokyo, Japan, normal range
to 47 pg/ml), and aldosterone (Coat-a-Coung, DPC, Los
ngeles, California, normal range 10 to 105 pg/ml). The
nterassay and intra-assay precision (coefficient of variation)
f NE was 4.7% and 3.6%. Those of Epi were 3.9% and
.4%. Those of PRA were 4.0% and 2.5%. The interassay
nd intra-assay coefficients of variation were 7.7%, 7.2% in
ng II and 6.5%, 3.2% in aldosterone.
tatistical analysis. Continuous variables were presented
s mean  SD and categorical variables as absolute and
elative frequencies (%). Differences between the 2
roups were analyzed using a paired t test for continuous
ariables and the McNemar test for categorical variables.
n each group, between at-rest and at-peak exercise,
eurohormonal data were compared using a paired t test.
o normalize the distribution, a natural logarithmic
ransformation was applied to variables that were not in
he normal distribution. A p value of 0.05 was consid-
red to be statistically significant. All statistical analyses
ere performed using SPSS software (version 13.0, SPSS
nc., Chicago, Illinois).
esults
aseline characteristics. Clinical characteristics of the
tudy population are presented in Table 1.
There were no significant differences in clinical variables
uch as body mass index, smoking, diabetes mellitus, and
yslipidemia. Four subjects were treated with statins, but
here were no significant differences between the groups.
here were no subjects who were taking insulin-sensitizing
rugs such as thiazolidinediones. In addition, there were no
ubjects on exogenous hormone therapy, either contracep-
ives or post-menopausal hormone treatment. Systolic BP,
iastolic BP, pulse pressure, and heart rate at rest were not
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July 22, 2008:287–92 Angiotensin II and Exercise BPifferent between the groups. There was no difference in
V, end-systolic pressure, and arterial elastance between the
roups. Left ventricular ejection fraction, LV mass index,
elative wall thickness, and left atrium volume index were
lso similar in the 2 groups.
emodynamic response to exercise. Total exercise dura-
ion was similar between the 2 groups. The reason for
topping exercise was not different between the 2 groups.
he most common limiting symptom was leg fatigue.
eak systolic and peak diastolic BP during exercise and
ncrement of systolic and diastolic BP were significantly
igher in Group II compared with that in Group I
ecause of the study design. Heart rate at rest was not
ifferent between 2 groups, but heart rate at peak exercise
as significantly higher in Group II compared with that
f Group I (Table 2).
eurohormonal response to exercise. There were no
ignificant differences in resting PRA, aldosterone, and
atecholamine level between 2 groups. The PRA, aldoste-
one, and catecholamine levels increased during exercise, but
here were no significant differences between groups. How-
ver, log Ang II at rest (Group I 0.78  0.32 vs. Group II
.98  0.38, p  0.004) and peak exercise (0.84  0.35 vs.
.17 0.51, p 0.001) and the magnitude of increment of
og Ang II with exercise (0.06  0.12 vs. 0.19  0.20, p 
.003) were significantly higher in Group II subjects (Table
, Fig. 1). These different neurohormonal responses to
xercise between the 2 groups were consistent in both
aseline Characteristics of the Study Subjects
Table 1 Baseline Characteristics of the Study Subjects
Group I
(n  36)
Group II
(n  36) p Value*
Age, yrs 50 16 50 16 1.000
Gender, M:F 18:18 18:18 1.000
Height, cm 163.4 8.7 163.9 8.8 0.779
Weight, kg 64.4 10.4 67.1 10.9 0.209
Body surface area, m2 1.70 0.17 1.74 0.17 0.282
Body mass index, kg/m2 24.0 2.6 24.9 3.1 0.117
Diabetes mellitus, n (%) 2 (5.6) 4 (11.2) 0.453
Dyslipidemia, n (%) 4 (11.2) 5 (13.9) 1.000
Smoking, n (%) 8 (22.4) 13 (36.1) 0.267
Statin, n (%) 1 (2.8) 3 (8.3) 0.500
Resting SBP, mm Hg 131 9 130 11 0.450
Resting DBP, mm Hg 80 9 79 10 0.540
Resting PP, mm Hg 51 9 51 11 0.930
Resting HR, beats/min 64 9 65 10 0.446
Resting ESP, mm Hg 115 15 114 15 0.101
Stroke volume, ml 67.6 12.9 67.7 12.0 0.978
Ea, mm Hg/ml 1.72 0.41 1.71 0.41 0.271
LVEF, % 67.5 6.1 67.9 5.8 0.785
LV mass index, g/m2 92.6 20.6 92.1 15.4 0.909
Relative wall thickness 0.38 0.06 0.39 0.06 0.636
LA volume index, ml/m2 21.3 6.6 21.0 6.6 0.854
p  0.05 is considered statistically significant.
DBP diastolic blood pressure; Ea arterial elastance; ESP end-systolic pressure; HR heart
ate; LA  left atrium; LV  left ventricle; LVEF  left ventricular ejection fraction; PP  pulse
ressure; SBP  systolic blood pressure.enders.
*iscussion
he present study demonstrated that an exaggerated BP
esponse to exercise was associated with augmented rise of
ng II during exercise. Catecholamines such as NE and Epi
lso increased during exercise, but there was no significant
ifference between the 2 different BP response groups.
The mechanism of an exaggerated BP response to exer-
ise is poorly understood. Several mechanisms for this
nique phenomenon have been proposed. The sympatho-
drenal and renin-angiotensin systems play an important
ole in BP control and regulation of cardiovascular function
uring exercise (13). An exaggerated BP response to exer-
ise has been thought to be related to excess stimulation of
he sympathetic nervous system and increased activation of
he renin-angiotensin-aldosterone system (6 – 8). The
enin-angiotensin and sympathoadrenal systems do not
perate independently but mutually interact with each other
n accomplishing their cardiovascular regulatory function
14,15). In our study, all neurohormones were increased
ith exercise compared with at rest. Plasma catecholamine
as increased as expected, but no difference was found
etween subjects with or without an exaggerated BP re-
ponse to exercise. This result can be explained by 2 factors
nfluencing the neurohormonal response. First, we selected
nly normotensive subjects at rest, although most of all
revious studies had focused on neurohormonal changes in
ypertensive patients. Second, in the present study, most of
he subjects underwent exercise workloads of 5 to 7 meta-
olic equivalents, equivalent to routine daily activities.
ecause of these factors, the amount of catecholamine
ecreted by the sympathetic nerve endings might not be
ufficient enough to increase its systemic concentration
ith a statistical significance. However, in the same
etting, Ang II level at peak exercise was significantly
ncreased in subjects with an exaggerated BP response to
emodynamic Response to Exercise
Table 2 Hemodynamic Response to Exercise
Group I
(n  36)
Group II
(n  36) p Value*
Total exercise duration, s 617 203 636 184 0.652
METs 6.1 1.4 6.2 1.3 0.339
Peak-exercise SBP, mm Hg 164 27 200 20 0.001
Peak-exercise DBP, mm Hg 88 16 94 18 0.019
Peak-exercise HR, beats/min 120 21 130 20 0.012
Increment of SBP, mm Hg 33 19 73 19 0.001
Increment of DBP, mm Hg 8 14 15 19 0.001
Increment of HR, beats/min 56 20 65 18 0.070
Reason for stopping exercise, n (%)
Dyspnea 8 (22.2) 9 (25.0) NS
Chest discomfort 0 (0.0) 1 (2.8) NS
Leg fatigue 23 (63.9) 22 (61.1) NS
Others 4 (11.1) 5 (13.9) NSp  0.05 is considered statistically significant.
MET  metabolic equivalent; other abbreviations as in Table 1.
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Angiotensin II and Exercise BP July 22, 2008:287–92xercise. There was indirect evidence that Ang II is an
mportant neurohormone in subjects with an abnormal
P rise. Warner et al. (16) found that 2 weeks of therapy
ith the Ang II receptor blocker reduced peak systolic
P by a mean of 33 mm Hg during exercise in patients
ith an exaggerated BP response to exercise. This obser-
ation suggested the role of Ang II acting through Ang I
eceptors in contributing to an exaggerated BP response
o exercise. However, that study also included hyperten-
ive patients who were taking a variety of common
ntihypertensive medications. Furthermore, the neuro-
ormonal measurements were not performed. The results
f the present study provide the role of Ang II on an
xaggerated BP response to exercise.
tudy limitations. Limitations of this study need to be
ddressed. First, the exercise was performed in the supine
osition using a bicycle ergometer. It is possible that the
eurohormonal response to exercise might be different with
he response to upright exercise. Second, habitual physical
ctivity was not taken into account in this study, although
hat has been considered as an important factor of neuro-
ormonal response to exercise. However, the subjects of 2
ifferent groups performed a similar amount of symptom-
imited exercise, and total exercise duration was not different
etween the 2 groups. Therefore, we think that the habitual
hysical activity might have been similar between the 2
roups. Third, studied subjects had some comorbidities,
uch as diabetes mellitus, smoking, and dyslipidemia, which
ould have confounding effects. However, we compared the
eurohormonal changes of the exaggerated BP response
roup with age- and gender-matched control subjects, and
he baseline characteristics including comorbidities were not
ignificantly different between the 2 groups. Fourth, the
articipants in the study were all Asian, and it is possible
hat results from the present study may not be generalizable
ontinued
Table 3 Continued
Neurohormones Group I (n  36) Group II (n  36) p Value*
Log ALDO, pg/ml
Rest
All 1.46 0.33 1.46 0.35 0.912
Men 1.42 0.35 1.54 0.33 0.873
Women 1.49 0.31 1.39 0.37 0.989
Peak exercise
All 1.54 0.31 1.59 0.36 0.532
Men 1.55 0.30 1.65 0.35 0.947
Women 1.54 0.32 1.52 0.37 0.348
Increment
All 0.09 0.17 0.12 0.22 0.524
Men 0.12 0.17 0.11 0.14 0.761
Women 0.05 0.17 0.13 0.28 0.154
p  0.05 is considered statistically significant.
ALDO  aldosterone; Ang  angiotensin; BP  blood pressure; Epi  epinephrine; NE 
orepinephrine; PRA  plasma renin activity.eurohormonal Response to Exercise in Subjectsith or Without an Exaggerated BP Responso Exe cise
Table 3
Neurohormonal Response to Exercise in Subjects
With or Without an Exaggerated BP Response
to Exercise
Neurohormones Group I (n  36) Group II (n  36) p Value*
Log NE, pg/ml
Rest
All 2.35 0.24 2.37 0.20 0.951
Men 2.31 0.24 2.35 0.20 0.251
Women 2.39 0.23 2.38 0.20 0.237
Peak exercise
All 2.43 0.26 2.48 0.22 0.453
Men 2.36 0.20 2.45 0.28 0.062
Women 2.50 0.29 2.51 0.15 0.695
Increment
All 0.08 0.31 0.12 0.29 0.521
Men 0.04 0.07 0.11 0.09 0.692
Women 0.10 0.08 0.12 0.06 0.626
Log Epi, pg/ml
Rest
All 1.69 0.22 1.67 0.36 0.558
Men 1.61 0.22 1.64 0.44 0.304
Women 1.75 0.20 1.70 0.27 0.121
Peak exercise
All 1.80 0.25 1.81 0.23 0.598
Men 1.81 0.30 1.82 0.21 0.681
Women 1.78 0.20 1.80 0.25 0.738
Increment
All 0.10 0.28 0.15 0.32 0.299
Men 0.19 0.35 0.19 0.37 0.451
Women 0.04 0.18 0.11 0.28 0.055
Log PRA, ng/ml/h
Rest
All 0.10 0.44 0.12 0.45 0.773
Men 0.21 0.45 0.21 0.38 0.724
Women 0.03 0.41 0.02 0.51 0.967
Peak exercise
All 0.22 0.37 0.29 0.35 0.372
Men 0.33 0.40 0.39 0.35 0.897
Women 0.10 0.31 0.18 0.33 0.121
Increment
All 0.09 0.22 0.14 0.33 0.473
Men 0.12 0.20 0.18 0.24 0.897
Women 0.07 0.25 0.10 0.40 0.121
Log Ang II, pg/ml
Rest
All 0.78 0.32 0.98 0.38 0.004
Men 0.78 0.27 0.98 0.32 0.009
Women 0.77 0.38 0.98 0.44 0.167
Peak exercise
All 0.84 0.35 1.17 0.51 0.001
Men 0.86 0.33 1.18 0.45 0.002
Women 0.81 0.38 1.16 0.57 0.036
Increment
All 0.06 0.12 0.19 0.20 0.003
Men 0.08 0.11 0.19 0.20 0.016
Women 0.04 0.14 0.18 0.21 0.034o other ethnic and racial groups.
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July 22, 2008:287–92 Angiotensin II and Exercise BPerspectives. Recently, the early pharmacologic treatment
or preventing hypertension has been issued. In the TROPHY
TRial Of Preventing HYpertension) study, it has been
emonstrated that treatment with Ang II receptor blocker
educed the risk of hypertension in subjects with pre-
ypertension (17,18). We believe that an exaggerated BP
esponse to exercise is not a benign phenomenon, but the
reatment strategy is uncertain. Treating the exaggerated BP
esponse during exercise in subjects without hypertension is
till controversial, and there are no guidelines for medical
herapy, although it is associated with adverse cardiovascular
utcomes. From the results of this study, Ang II can be
Figure 1 Neurohormonal Response to Exercise
(A) Norepinephrine; (B) epinephrine; (C) angiotensin II.onsidered the most important neurohormone affecting an dxaggerated BP response to exercise. The neurohormonal
bservation in this study might provide important informa-
ion about the mechanism of an exaggerated BP response to
xercise. It can be suggested that Ang II receptor blockers
an be recommended in subjects with an exaggerated BP
esponse to exercise.
onclusions
he exaggerated BP response to exercise was associated
ith augmented production of Ang II during exercise. Our
ata may provide important information about the neuro-
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xercise.
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